AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 28 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $23,198,000 | +11.0% | 25,780,000 | -1.5% | 0.21% | -1.9% |
| Q2 2020 | $20,903,000 | +3.4% | 26,180,000 | 0.0% | 0.21% | -28.3% |
| Q1 2020 | $20,208,000 | -16.4% | 26,180,000 | -8.7% | 0.29% | +4.3% |
| Q4 2019 | $24,182,000 | +3.0% | 28,680,000 | 0.0% | 0.28% | -5.7% |
| Q3 2019 | $23,489,000 | +1.8% | 28,680,000 | 0.0% | 0.30% | -1.3% |
| Q2 2019 | $23,081,000 | -7.9% | 28,680,000 | 0.0% | 0.30% | -11.7% |
| Q1 2019 | $25,051,000 | -4.0% | 28,680,000 | 0.0% | 0.34% | +9.3% |
| Q4 2018 | $26,082,000 | -20.6% | 28,680,000 | -8.9% | 0.31% | -18.1% |
| Q3 2018 | $32,853,000 | +2.6% | 31,474,000 | +1.4% | 0.38% | -7.7% |
| Q2 2018 | $32,023,000 | +211.0% | 31,050,000 | +214.6% | 0.41% | +211.3% |
| Q1 2018 | $10,296,000 | -13.1% | 9,870,000 | -18.4% | 0.13% | +1.5% |
| Q3 2017 | $11,854,000 | -48.8% | 12,100,000 | -49.8% | 0.13% | -55.4% |
| Q2 2017 | $23,162,000 | – | 24,100,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 1,500,000 | $1,492,000 | 2.87% |
| Telemetry Investments, L.L.C. | 8,000,000 | $7,780,000 | 2.78% |
| Context Capital Management, LLC | 3,500,000 | $3,405,000 | 2.28% |
| Kamunting Street Capital Management, L.P. | 2,500,000 | $2,431,000 | 1.54% |
| BASSO CAPITAL MANAGEMENT, L.P. | 12,205,000 | $11,824,000 | 1.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 17,500,000 | $17,269,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 32,375,000 | $31,485,000 | 1.04% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,328,000 | 1.04% |
| City Financial Investment Co Ltd | 12,500,000 | $12,168,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,250,000 | $15,747,000 | 0.71% |